Pushkal Garg
Director, SQZ Biotechnologies Co.
Companies
- Alnylam PharmaceuticalsCMO & EVP Dev & Med Affairs Jan 4, 2022 to now1
- SQZ Biotechnologies CoBoard member Oct 29, 2020 to Jun 15, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Alnylam Pharmaceuticals ALNY18,943 shares3$4.5M at $235.58Mar 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 5, 2026Sold 500 shares at $326.08 of Alnylam Pharmaceuticals3
- Mar 5, 2026Sold 510 shares at $324.59 of Alnylam Pharmaceuticals3
- Mar 5, 2026Sold 740 shares at $323.55 of Alnylam Pharmaceuticals3
- Mar 5, 2026Sold 654 shares at $322.33 of Alnylam Pharmaceuticals3
- Mar 4, 2026Sold 208 shares at $325.67 of Alnylam Pharmaceuticals3
- Mar 4, 2026Sold 272 shares at $324.88 of Alnylam Pharmaceuticals3
- Mar 4, 2026Sold 767 shares at $323.84 of Alnylam Pharmaceuticals3
- Mar 4, 2026Sold 350 shares at $323.01 of Alnylam Pharmaceuticals3
- Mar 4, 2026Sold 289 shares at $321.82 of Alnylam Pharmaceuticals3
- Mar 4, 2026Sold 215 shares at $320.81 of Alnylam Pharmaceuticals3
- Mar 4, 2026Sold 102 shares at $320.01 of Alnylam Pharmaceuticals3
- Mar 4, 2026Sold 106 shares at $319.03 of Alnylam Pharmaceuticals3
- Mar 3, 2026Sold 463 shares at $321.50 of Alnylam Pharmaceuticals4
- Mar 3, 2026Sold 640 shares at $320.48 of Alnylam Pharmaceuticals4
- Mar 3, 2026Sold 317 shares at $319.06 of Alnylam Pharmaceuticals4
- Mar 3, 2026Sold 355 shares at $316.74 of Alnylam Pharmaceuticals4
- Mar 2, 2026Sold 42 shares at $332.64 of Alnylam Pharmaceuticals4
- Mar 2, 2026Sold 101 shares at $331.93 of Alnylam Pharmaceuticals4
- Mar 2, 2026Sold 87 shares at $330.85 of Alnylam Pharmaceuticals4
- Mar 2, 2026Sold 182 shares at $329.71 of Alnylam Pharmaceuticals4
- Mar 2, 2026Sold 107 shares at $328.71 of Alnylam Pharmaceuticals4
- Mar 2, 2026Sold 353 shares at $327.67 of Alnylam Pharmaceuticals4
- Mar 2, 2026Sold 421 shares at $326.81 of Alnylam Pharmaceuticals4
- Mar 2, 2026Sold 277 shares at $325.63 of Alnylam Pharmaceuticals4
- Mar 2, 2026Sold 97 shares at $324.65 of Alnylam Pharmaceuticals4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARSQZ Biotechnologies Co, Board member
- 3
- 4SEC EDGARForm 4 filed Mar 4, 2026